Biogen

What’s driving pharma’s layoffs in 2025
Pharma Voice
Mon, 03/10/25 - 09:27 am
layoffs
CRISPR Therapeutics
Galapagos
Atara Biotherapeutics
Bristol Myers Squibb
Eisai
Biogen
Biogen, Apple study finds smart devices can track cognition
Pharmaphorum
Fri, 03/7/25 - 11:07 am
Biogen
Apple
wearables
smart devices
cognitive impairment
Medtech
NICE agrees to look again at Alzheimer's drug Leqembi
Pharmaphorum
Thu, 03/6/25 - 10:59 am
Eisai
Biogen
Leqembi
Alzheimer's disease
UK
NICE
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Voyager Therapeutics
RNA
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Australia stands firm on 'no' to Alzheimer's drug Leqembi
Pharmaphorum
Mon, 03/3/25 - 10:53 am
Eisai
Biogen
Australia
Alzheimer's disease
Leqembi
Leqembi, after delay, gets back on track toward EU approval
BioPharma Dive
Sun, 03/2/25 - 09:35 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Europe
Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline
Fierce Biotech
Tue, 02/18/25 - 11:12 am
Biogen
R&D
Stoke Therapeutics
Dravet syndrome
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
CNBC
Wed, 02/12/25 - 11:08 am
Biogen
earnings
Leqembi
Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase 3 program
Fierce Biotech
Wed, 02/12/25 - 10:03 am
Biogen
Royalty Pharma
lupus
litifilimab
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Fri, 01/31/25 - 11:16 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Yahoo/Reuters
Mon, 01/27/25 - 11:38 am
Biogen
SAGE Therapeutics
M&A
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Biogen
Eisai
Leqembi
Alzheimer's disease
FDA
US/EU regulators start review of Biogen's high-dose Spinraza
Pharmaphorum
Thu, 01/23/25 - 11:39 am
Biogen
Spinraza
SMQA
Biogen research team hit by layoffs as company shifts resources to external opportunities
Fierce Biotech
Wed, 01/22/25 - 07:29 pm
Biogen
R&D
layoffs
Sage sues Biogen as analyst detects little interest in buyout at original offer price
Fierce Pharma
Tue, 01/21/25 - 07:02 pm
SAGE Therapeutics
legal
Biogen
M&A
zuranolone
Federal watchdog cites concerns with FDA’s accelerated approval process
BioPharma Dive
Wed, 01/15/25 - 11:48 pm
HHS
FDA
accelerated approvals
Aduhelm
Biogen
Under pressure to deal, Biogen executives deflect urgency at JPM25
BioSpace
Wed, 01/15/25 - 11:33 am
Biogen
JPMHC 2025
M&A
Chris Viehbacher
SAGE Therapeutics
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Yahoo/Investopedia
Mon, 01/13/25 - 10:54 am
SAGE Therapeutics
Biogen
M&A
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Alzheon
Private Medicare plans must cover Biogen's ALS drug, US agency says
Yahoo/Reuters
Thu, 12/12/24 - 11:45 pm
CMS
Medicare
Biogen
ALS
Qalsody

Pages